ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis
2025
发表期刊HEPATOLOGY (IF:12.9[JCR-2023],15.5[5-Year])
ISSN0270-9139
EISSN1527-3350
卷号81期号:1
发表状态已发表
DOI10.1097/HEP.0000000000000704
摘要["Background and Aims: Cross talk between tumor cells and immune cells enables tumor cells to escape immune surveillance and dictate responses to immunotherapy. Previous studies have identified that downregulation of the glycolytic enzyme fructose-1,6-bisphosphate aldolase B (ALDOB) in tumor cells orchestrated metabolic programming to favor HCC. However, it remains elusive whether and how ALDOB expression in tumor cells affects the tumor microenvironment in HCC.","Approach and Results: We found that ALDOB downregulation was negatively correlated with CD8(+) T cell infiltration in human HCC tumor tissues but in a state of exhaustion. Similar observations were made in mice with liver-specific ALDOB knockout or in subcutaneous tumor models with ALDOB knockdown. Moreover, ALDOB deficiency in tumor cells upregulates TGF-beta expression, thereby increasing the number of Treg cells and impairing the activity of CD8(+) T cells. Consistently, a combination of low ALDOB and high TGF-beta expression exhibited the worst overall survival for patients with HCC. More importantly, the simultaneous blocking of TGF-beta and programmed cell death (PD) 1 with antibodies additively inhibited tumorigenesis induced by ALDOB deficiency in mice. Further mechanistic experiments demonstrated that ALDOB enters the nucleus and interacts with lysine acetyltransferase 2A, leading to inhibition of H3K9 acetylation and thereby suppressing TGFB1 transcription. Consistently, inhibition of lysine acetyltransferase 2A activity by small molecule inhibitors suppressed TGF-beta and HCC.","Conclusions: Our study has revealed a novel mechanism by which a metabolic enzyme in tumor cells epigenetically modulates TGF-beta signaling, thereby enabling cancer cells to evade immune surveillance and affect their response to immunotherapy."]
URL查看原文
收录类别SCI
语种英语
资助项目National Key R&D Program of China["2018YFA0800301","2022YFC2503303"] ; National Natural Science Foundation of China["32150710522","32241017","92157108"]
WOS研究方向Gastroenterology & Hepatology
WOS类目Gastroenterology & Hepatology
WOS记录号WOS:001379604900026
出版者LIPPINCOTT WILLIAMS & WILKINS
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/470982
专题生命科学与技术学院
生命科学与技术学院_特聘教授组_尹慧勇组
生命科学与技术学院_硕士生
生命科学与技术学院_博士生
通讯作者Li, Nan; Tao, Yongzhen; Yin, Huiyong
作者单位
1.Chinese Acad Sci, Shanghai Inst Nutr & Hlth SINH, CAS Key Lab Nutr Metab & Food Safety Res, Shanghai, Peoples R China
2.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
3.City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China
4.Shanghai Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 1, Ward 1, Shanghai, Peoples R China
5.Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
6.City Univ Hong Kong, State Key Lab Marine Pollut SKLMP, Hong Kong, Peoples R China
第一作者单位生命科学与技术学院
通讯作者单位生命科学与技术学院
推荐引用方式
GB/T 7714
Yin, Chunzhao,Zhang, Cunzhen,Wang, Yongqiang,et al. ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis[J]. HEPATOLOGY,2025,81(1).
APA Yin, Chunzhao.,Zhang, Cunzhen.,Wang, Yongqiang.,Liu, Guijun.,Wang, Ningning.,...&Yin, Huiyong.(2025).ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis.HEPATOLOGY,81(1).
MLA Yin, Chunzhao,et al."ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis".HEPATOLOGY 81.1(2025).
条目包含的文件
条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Yin, Chunzhao]的文章
[Zhang, Cunzhen]的文章
[Wang, Yongqiang]的文章
百度学术
百度学术中相似的文章
[Yin, Chunzhao]的文章
[Zhang, Cunzhen]的文章
[Wang, Yongqiang]的文章
必应学术
必应学术中相似的文章
[Yin, Chunzhao]的文章
[Zhang, Cunzhen]的文章
[Wang, Yongqiang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。